The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome
Abstract
Most of the small number of cases of poliomyelitis which occur in countries where Sabin's attenuated poliovirus vaccines are used are temporally associated with administration of vaccine and involve polioviruses of types 2 and 3 (ref. 1). Recent studies have provided convincing evidence that the Sabin type 2 and 3 viruses themselves may revert to a neurovirulent phenotype on passage in man. We report here that a point mutation in the 5' noncoding region of the genome of the poliovirus type 3 vaccine consistently reverts to wild type in strains isolated from cases of vaccine-associated poliomyelitis. Virus with this change is rapidly selected on passage through the human gastrointestinal tract. The change is associated with a demonstrable increase in the neurovirulence of the virus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Soon after vaccination, the majority of vaccinees shed polioviruses with a high frequency of such mutations (Evans et al., 1985, Stern et al., 2017), indicating that the structural stability of domV is under strong positive selection in the human gut.”
From Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence (2020) · cites this paper as Evans et al., 1985
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Complete nucleotide sequences of all three poliovirus serotype genomes
Toyoda, H., Kohara, M., Kataoka, Y., Suganuma, T., Omata, T., Imura, N., & Nomoto, A. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90084-6 · Cited by 418
Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome.
Nomoto, A., Omata, T., Toyoda, H., Kuge, S., Horie, H., Kataoka, Y., Genba, Y., Nakano, Y., & Imura, N. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.19.5793 · Cited by 308
The complete nucleotide sequence of a common cold virus: human rhinovlrus 14
Stanway, G., Hughes, P. J., Mountford, R. C., Minor, P. D., & Almond, J. W. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.20.7859 · Cited by 254
Self-citationStanway, G., Hughes, P. J., Mountford, R. C., Reeve, P., Minor, P. D., Schild, G. C., & Almond, J. W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.5.1539 · Cited by 188
Self-citationSome simple computational methods to improve the folding of large RNAs
Jacobson, A. B., Good, L., Simonetti, J., & Zuker, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.45 · Cited by 164
Multiple Genetic Changes Can Occur in the Oral Poliovaccines upon Replication in Humans
Kew, O. M., Nottay, B. K., Hatch, M. H., Nakano, J. H., & Obijeski, J. F. (1981) · Journal of General Virology · doi:10.1099/0022-1317-56-2-337 · Cited by 149
Reversion to neurovirulence of the live-attenuated Sabin type 3 oral pollovirus vaccine
Cann, A. J., Stanway, G., Hughes, P. J., Minor, P. D., Evans, D. M. A., Schild, G. C., & Almond, J. W. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.20.7787 · Cited by 146
Self-citationCritical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3
Evans, D. M. A., Minor, P. D., Schild, G., & Almond, J. W. (1983) · Nature · doi:10.1038/304459a0 · Cited by 111
Self-citationComparative biochemical studies of type 3 poliovirus
Minor, P. D. (1980) · Journal of Virology · doi:10.1128/jvi.34.1.73-84.1980 · Cited by 79
Self-citation
Research works printed but not linked: 2
- Assaad, F. & Cockburn, W. C. Bull Wld Hlth Org. 60, 231–242 (1982).
- Tech. Rep. Ser. Wld Hlth Org. 687, 134 (1983).
Cited by
Items 401–438 of 438
Ljungan virus - prevalence in rodents and virus pathogenesis
Robert Koch-Institute Berlin (2010) · Cited by 1
Horie, H., Fujii, Y., Katabami, K., Iwama, M., & Yamada, A. (2007) · 和漢医薬学雑誌 · doi:10.11339/jtm.24.156 · Cited by 2
Modlin, J. F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00171-5 · Cited by 1
Genetic Variation of Foot and Mouth Disease Virus
Beck, E. (1988) · Developments in veterinary virology · doi:10.1007/978-1-4613-2091-3_28 · Cited by 1
Enterovirus Infection of Cultured Human Pancreatic Islets
Smura, T., & Roivainen, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4051-2_28 · Cited by 2
Stability of attenuated poliovirus strain genotypes in the human intestinal tract
Minor, P. D., Dunn, G., Almond, J. W., & Macadam, A. J. (1993) · Springer eBooks · doi:10.1007/978-3-7091-9278-8_32 · Cited by 1
Self-citationFeasible Improvements in Vaccines in the Expanded Programme on Immunization
McIntosh, K. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_3.s530 · Cited by 1
“related a single base change from uridine to cytidine at position 472 in the noncoding region of poliovirus type 3 with conversion from attenuation to neurovirulence [18].”
BackgroundRacaniello, V. R. (2009) · Elsevier eBooks · doi:10.1016/b978-012373944-5.00312-6 · Cited by 2
Effect of Intestinal Microenvironment on Mucosal Immune Response to Viruses
Abraham, R., & Ogra, P. L. O. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-732085-4.50033-3 · Cited by 1
The Period of Biochemistry and Molecular Genetics
Gräfe, A. (1991) · Springer eBooks · doi:10.1007/978-3-642-75250-6_6
Current and Future Approaches to Vaccination Against Virus Diseases
Howard, C. R. (1994) · Springer eBooks · doi:10.1007/978-94-011-1430-1_10
Brief History of Clinical Trials on Viral Vaccines
Brooks, M. J., Sasadeusz, J., & Tannock, G. A. (2010) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse232
Μοριακή ταυτοποίηση και διερεύνηση της εξέλιξης των echo ιών
Κοτταρίδη, Χ. (2007) · doi:10.12681/eadd/17239
The Molecular and Functional Basis of Poliovirus Attenuation and Host Range
Racaniello, V. R. (1989) · Springer eBooks · doi:10.1007/978-1-4613-8890-6_3
Kato, Z., Shimada, Y., Ishiko, H., & Kondo, N. (2009) · The Open Pediatric Medicine Journal · doi:10.2174/1874309900903010031
Reiss, C. S. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541728.003
Dynamics of genomic variation in poliovirus in Africa
Chezzi, C. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Effect of Mucosal Microenvironment on Immune Response to Viruses
Abraham, R., & Ogra, P. L. O. (1992) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-3410-5_12
Poliovirus proves IRES-istible in vivo
Murray, J. C. (2004)
Introduction: immunity, diagnosis, vector, and beneficial uses of neurotropic viruses
Reiss, C. S. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541728.018
Shimizu, M., Tokita, H., Hoshiyama, N., TAKAHASHI, Y., KOJIMA, M., OKADA, S., Tsuda, F., Sugiyama, Y., Yotsumoto, S., & Okamoto, H. (1991) · Kanzo · doi:10.2957/kanzo.32.141
Racaniello, V. R. (1992) · Elsevier eBooks · doi:10.1016/b978-0-7506-9265-6.50015-4
Development of candidates for new type 2 and type 3 oral poliovirus recombinant vaccines
Kohara, M., & Nomoto, A. (1993) · Springer eBooks · doi:10.1007/978-3-7091-9278-8_29
The application of molecular biology to the development of new vaccines against poliomyelitis
Almond, J. W. (1989) · Springer eBooks · doi:10.1007/978-94-009-1067-6_7
Self-citationKoike, S., & Nomoto, A. (2014) · ASM Press eBooks · doi:10.1128/9781555816698.ch21
Baxt, B., & Rieder, E. A. (2004) · CRC Press eBooks · doi:10.1201/9781420037968.ch7 · Cited by 11
Calenoff, M. A., Jubelt, B., & Lipton, H. L. (1989) · Springer eBooks · doi:10.1007/978-1-4613-1675-6_9
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01311-1
Dittmann, S. (1989) · Side effects of drugs annual · doi:10.1016/s0378-6080(89)80039-x
(2010) · Elsevier eBooks · doi:10.1016/b978-0-444-53272-5.50009-1
(2006) · Elsevier eBooks · doi:10.1016/b0-44-451005-2/00546-5
Genetic Engineering Applied to the Development of Vaccines
Murray, K., Stahl, S. J., & Ashton‐Rickardt, P. G. (1990) · Springer eBooks · doi:10.1007/978-1-4613-1565-0_3
Immunological aspects of the prevention of viral diseases. WHO Workshop.
(1987) · Europe PMC (PubMed Central)
Enteroviruses Associated with Acute Flaccid Paralysis
Laxmivandana, R., Cherian, S., & Chitambar, S. D. (2024) · Springer eBooks · doi:10.1007/978-981-97-4480-0_8 · Cited by 1
Kim, D., McCarthy, F., Li, K. K., Chalkley, R. J., Pak, J. E., Elias, J. E., & Aviner, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.19.660622
“Previous studies have shown that A-to-G substitutions in the 5’ UTR of polio reduce the translation efficiency of viral genomes and limit neuroinvasion and neurovirulence 76,77 , although it is unclear whether these mutations are introduced by ADARs.”
Xu, X., Ma, S., Liu, Z., Yuan, H., Wang, Y., Chen, M., Du, M., Kan, H., Wang, Z., Chong, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25884998
Metadata
- Authors
- Evans, D. M. A., Dunn, G., Minor, P. D., Schild, G. C., Cann, A. J., Stanway, G., Almond, J. W., Currey, K., & Maizel, J. V.
- Affiliations
- National Institute for Biological Standards and Control (GB)
- University of Leicester (GB)
- National Institutes of Health (US)
- ORCID
- Cann, A. J.
- Venue
- Nature
- Published
- 1985-04
- Volume
- 314
- Issue
- 6011
- Pages
- 548-550
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2044967254
- Cited by
- 440
- References
- 17
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 7 · 2014: 12 · 2013: 7 · 2012: 3
- FWCI
- 21.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- vaccine-associated poliomyelitis, neurovirulence, point mutations, 5' untranslated region, genetic reversion, vaccine strain selection
- MeSH terms
- Base Sequence, DNA, Viral, Feces, Genes, Viral, Humans, Infant, Mutation, Nucleic Acid Conformation, Poliomyelitis, Poliovirus Vaccine, Oral, RNA, Viral, Structure-Activity Relationship, Vaccination, Poliovirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.